Protalix BioTherapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2008 | — | $44.3M | $42.6M |
| Dec 2009 | — | $15.9M | $81.3M |
| Jun 2010 | — | $-1.6M | $55.0M |
| Sep 2010 | — | $-3.5M | $44.4M |
| Dec 2010 | — | $-11.3M | $35.9M |
| Mar 2011 | — | $4.7M | $50.2M |
| Jun 2011 | $4.5M | $-8.7M | $44.1M |
| Sep 2011 | $4.7M | $-17.4M | $34.6M |
| Dec 2011 | $6.6M | $-26.1M | $27.0M |
| Mar 2012 | — | $-6.5M | $45.6M |
| Jun 2012 | $4.7M | $7.9M | $59.3M |
| Sep 2012 | $2.8M | $4.8M | $50.2M |
| Dec 2012 | $5.4M | $-3.4M | $52.0M |
| Mar 2013 | $2.7M | $-6.3M | $41.9M |
| Jun 2013 | $376.0K | $-12.0M | $33.1M |
| Sep 2013 | — | $-16.7M | $91.4M |
| Dec 2013 | $2.4M | $-26.9M | $86.4M |
| Mar 2014 | — | $-33.6M | $77.7M |
| Jun 2014 | — | $-39.8M | $71.1M |
| Sep 2014 | — | $-47.7M | $60.3M |
| Dec 2014 | $912.0K | $-55.6M | $54.8M |
| Mar 2015 | — | $-61.2M | $48.0M |
| Jun 2015 | — | $-65.1M | $43.2M |
| Sep 2015 | — | $-68.5M | $34.2M |
| Dec 2015 | — | $10.9M | $76.4M |
| Mar 2016 | — | $2.7M | $66.7M |
| Jun 2016 | — | $-8.0M | $54.6M |
| Sep 2016 | — | $-15.1M | $51.3M |
| Dec 2016 | — | $-10.0M | $63.3M |
| Mar 2017 | — | $-68.5M | $48.0M |
| Jun 2017 | — | $-20.7M | $34.5M |
| Sep 2017 | — | $-26.1M | $33.5M |
| Dec 2017 | — | $-29.5M | $51.2M |
| Mar 2018 | — | $-35.4M | $41.3M |
| Jun 2018 | — | $-42.7M | $28.3M |
| Sep 2018 | — | $-47.9M | $41.9M |
| Dec 2018 | — | $-52.9M | $37.8M |
| Mar 2019 | — | $-59.9M | $30.4M |
| Jun 2019 | — | $-67.5M | $25.1M |
| Sep 2019 | — | $-70.8M | $21.4M |
| Dec 2019 | — | $-70.3M | $17.8M |
| Mar 2020 | — | $-30.9M | $14.2M |
| Jun 2020 | — | $-34.8M | $4.8M |
| Sep 2020 | — | $-33.3M | $13.5M |
| Dec 2020 | — | $-27.0M | $18.3M |
| Mar 2021 | — | $14.5M | $19.8M |
| Jun 2021 | — | $3.8M | $33.9M |
| Sep 2021 | — | $213.0K | $10.6M |
| Dec 2021 | — | $-6.0M | $39.0M |
| Mar 2022 | — | $-7.5M | $16.9M |
| Jun 2022 | — | $-9.9M | $12.5M |
| Sep 2022 | — | $-11.5M | $10.7M |
| Dec 2022 | — | $-10.6M | $17.1M |
| Mar 2023 | — | $1.0M | $33.0M |
| Jun 2023 | — | $39.0M | $48.2M |
| Sep 2023 | — | $38.2M | $20.4M |
| Dec 2023 | — | $33.6M | $23.6M |
| Mar 2024 | — | $29.8M | $27.2M |
| Jun 2024 | — | $28.6M | $23.4M |
| Sep 2024 | — | $32.4M | $27.4M |
| Dec 2024 | — | $43.2M | $19.8M |
| Mar 2025 | — | $45.2M | $19.5M |
| Jun 2025 | — | $49.9M | $17.9M |
| Sep 2025 | — | $52.9M | $13.6M |
| Dec 2025 | — | $48.2M | $14.7M |
| Mar 2026 | — | $67.2M | $41.0M |
| Jun 2026 | — | $71.4M | $27.4M |